Understanding keratoconus

Clinical and Experimental Ophthalmology

Volumn 29, Issue 6, 2001, Pages 339-

  Loughnan, M S ^a   Snibson, G R ^a  

^a ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ASTIGMATISM; CORNEA; CORNEA STROMA; DISEASE COURSE; EDITORIAL; EVIDENCE BASED MEDICINE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GLAUCOMA; HUMAN; KERATOCONUS; KERATOMILEUSIS; NEUROOPHTHALMOLOGY; PREVALENCE;

HUMANS; KERATOCONUS; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0035669919     PISSN: 14426404     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-9071.2001.00468.x     Document Type: Editorial

References (2)

1. Is the corneal degradation in keratoconus caused by matrix-metalloproteinases?
2. The genetics of keratoconus